Literature DB >> 24948121

Anticancer drugs: Hitting SYK in B-ALL leukaemia.

Charlotte Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24948121     DOI： 10.1038/nrd4371

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.

Authors:  Tatiana Perova; Ildiko Grandal; Lauryl M J Nutter; Eniko Papp; Irina R Matei; Joseph Beyene; Paul E Kowalski; Johann K Hitzler; Mark D Minden; Cynthia J Guidos; Jayne S Danska
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.